ANEMIA PREDICTS SUSTAINED VIROLOGIC RESPONSE IN CIRRHOTIC AND NON-CIRRHOTIC CHRONIC HEPATITIS C (CHC) PATIENTS TREATED WITH PEGINTERFERON alfa-2a AND RIBAVIRIN IN FOUR CLINICAL TRIALS

被引：0
|
作者：
Reau, N. [1 ]
Korner, E. J. [2 ]
Han, J. [2 ]
Jensen, D. M. [1 ]
机构：
[1] Univ Chicago Hosp, Ctr Liver Dis, Chicago, IL 60637 USA
[2] Genentech Inc, San Francisco, CA 94080 USA
来源：
JOURNAL OF HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
10.1016/S0168-8278(13)60894-6
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
892
引用
收藏
页码：S367 / S367
页数：1
相关论文
共 50 条
  • [1] Anemia Predicts Sustained Virological Response in Cirrhotic and Noncirrhotic Patients with Chronic Hepatitis C Treated with Peginterferon Alfa-2a and Ribavirin
    Reau N.S.
    Korner E.J.
    Han J.
    Jensen D.
    Current Hepatology Reports, 2015, 14 (1) : 53 - 59
  • [2] A Sustained Virologic Response Is Durable in Patients With Chronic Hepatitis C Treated With Peginterferon Alfa-2a and Ribavirin
    Swain, Mark G.
    Lai, Ming-Yang
    Shiffman, Mitchell L.
    Cooksley, W. Graham E.
    Zeuzem, Stefan
    Dieterich, Douglas T.
    Abergel, Armand
    Pessoa, Mario G.
    Lin, Amy
    Tietz, Andreas
    Connell, Edward V.
    Diago, Moises
    GASTROENTEROLOGY, 2010, 139 (05) : 1593 - 1601
  • [3] Rapid virologic response to peginterferon alfa and ribavirin treatment of chronic hepatitis C predicts sustained virologic response and relapse
    Poordad, F. Fred
    Kambili, Chrispin
    GASTROENTEROLOGY, 2008, 134 (04) : A830 - A830
  • [4] VIROLOGIC AND METABOLIC RESPONSES IN CHRONIC HEPATITIS C (CHC) PATIENTS WITH INSULIN RESISTANCE (IR) TREATED WITH PIOGLITAZONE AND PEGINTERFERON ALFA-2A PLUS RIBAVIRIN
    Harrison, S.
    Hamzeh, F. M.
    Lentz, E.
    Vierling, J. M.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S129 - S129
  • [5] Virologic and Metabolic Responses in Chronic Hepatitis C (CHC) Patients With Insulin Resistance (IR) Treated With Pioglitazone and Peginterferon Alfa-2a Plus Ribavirin
    Harrison, Stephen A.
    Hamzeh, Fayez M.
    Lentz, Ellen
    Vierling, John M.
    GASTROENTEROLOGY, 2010, 138 (05) : S790 - S790
  • [6] VIROLOGIC AND METABOLIC RESPONSES IN CHRONIC HEPATITIS C (CHC) PATIENTS WITH INSULIN RESISTANCE (IR) TREATED WITH PIOGLITAZONE AND PEGINTERFERON ALFA-2A PLUS RIBAVIRIN
    Vierling, John M.
    Hamzeh, Fayez M.
    Lentz, Ellen L.
    Harrison, Stephen
    HEPATOLOGY, 2009, 50 (04) : 1028A - 1029A
  • [7] Bone mineral density and bone turnover in non-cirrhotic patients with chronic hepatitis C and sustained virological response to antiviral therapy with peginterferon-alfa and ribavirin
    Redondo-Cerezo, E.
    Casado-Caballero, F.
    Martin-Rodriguez, J. L.
    Hernandez-Quero, J.
    Escobar-Jimenez, F.
    Gonzalez-Calvin, J. L.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 (06) : 1709 - 1715
  • [8] Bone mineral density and bone turnover in non-cirrhotic patients with chronic hepatitis C and sustained virological response to antiviral therapy with peginterferon-alfa and ribavirin
    E. Redondo-Cerezo
    F. Casado-Caballero
    J. L. Martin-Rodriguez
    J. Hernandez-Quero
    F. Escobar-Jimenez
    J. L. Gonzalez-Calvin
    Osteoporosis International, 2014, 25 : 1709 - 1715
  • [9] Association of Host Pharmacodynamic Effects and Virologic Response to Peginterferon Alfa-2a/Ribavirin in Patients With Chronic Hepatitis C
    Chung, Raymond T.
    Di Bisceglie, Adrian M.
    Poordad, Fred
    Hassanein, Tarek
    Zhou, Xiaolei
    Lentz, Ellen
    Prabhakar, Avi
    Hamzeh, Fayez M.
    GASTROENTEROLOGY, 2010, 138 (05) : S841 - S841
  • [10] ASSOCIATION OF HOST PHARMACODYNAMIC EFFECTS AND VIROLOGIC RESPONSE TO PEGINTERFERON ALFA-2A/RIBAVIRIN IN PATIENTS WITH CHRONIC HEPATITIS C
    Chung, R. T.
    Di Bisceglie, A.
    Poordad, F. F.
    Hassanein, T.
    Zhou, X.
    Lentz, E.
    Prabhakar, A.
    Hamzeh, F. M.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S106 - S107
12345